Analysts Set Teladoc Health, Inc. (NYSE:TDOC) Price Target at $7.64

Teladoc Health, Inc. (NYSE:TDOC) has been given a consensus rating of “Hold” by the twenty-one ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and six have issued a buy rating on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $7.6389.

A number of equities research analysts have issued reports on TDOC shares. Stifel Nicolaus decreased their target price on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Thursday, February 26th. Bank of America raised shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price target on the stock in a research report on Thursday, February 26th. JPMorgan Chase & Co. reduced their price objective on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, March 13th. BMO Capital Markets decreased their price objective on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a report on Thursday, February 26th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $9.00 target price (down from $12.00) on shares of Teladoc Health in a research note on Thursday, February 26th.

Teladoc Health Trading Down 3.2%

Teladoc Health stock opened at $5.28 on Friday. Teladoc Health has a one year low of $4.40 and a one year high of $9.77. The company’s fifty day moving average price is $5.23 and its two-hundred day moving average price is $6.84. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.77 and a quick ratio of 2.67. The company has a market capitalization of $941.04 million, a price-to-earnings ratio of -4.63 and a beta of 2.13.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. Teladoc Health had a negative return on equity of 9.13% and a negative net margin of 7.92%.The company had revenue of $642.27 million during the quarter, compared to analysts’ expectations of $635.33 million. During the same quarter in the previous year, the firm earned ($0.28) earnings per share. The business’s quarterly revenue was up .3% compared to the same quarter last year. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. On average, analysts forecast that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Transactions at Teladoc Health

In other news, CEO Charles Divita III sold 27,731 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total value of $152,243.19. Following the sale, the chief executive officer directly owned 364,784 shares of the company’s stock, valued at approximately $2,002,664.16. This trade represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.58% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently made changes to their positions in TDOC. Allianz Asset Management GmbH grew its holdings in Teladoc Health by 189.2% in the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock valued at $12,518,000 after buying an additional 1,059,458 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Teladoc Health by 4.2% during the third quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider’s stock worth $169,372,000 after buying an additional 891,732 shares during the last quarter. Jupiter Asset Management Ltd. acquired a new position in shares of Teladoc Health during the third quarter worth approximately $7,576,000. Monaco Asset Management SAM boosted its position in shares of Teladoc Health by 31.3% in the third quarter. Monaco Asset Management SAM now owns 755,000 shares of the health services provider’s stock valued at $5,836,000 after acquiring an additional 180,000 shares during the period. Finally, Hussman Strategic Advisors Inc. bought a new stake in shares of Teladoc Health in the third quarter valued at approximately $1,136,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Key Headlines Impacting Teladoc Health

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Pineal Capital publicly urged Teladoc to pursue cost cuts, consider a breakup and evaluate buybacks to unlock shareholder value — this activist push is the main catalyst supporting the stock’s upside potential. Activist Pineal Capital pushes Teladoc to consider split, other changes to boost value
• Positive Sentiment: Market reaction showed a short-lived boost after the activist’s recommendations surfaced, with reports noting a rally tied to expectations of buybacks or other shareholder-friendly actions. Teladoc Health stock rises after activist pushes for buyback
• Neutral Sentiment: TDOC was listed among “stocks to watch” in market roundups — attention/volume may stay elevated as investors await board/management response. Stocks to watch on Tuesday after market: RH, NKE, TDOC
• Negative Sentiment: Despite activist news, shares fell on the day — short-term selling and profit-taking occurred even as the broader market advanced. Teladoc (TDOC) Stock Sinks As Market Gains: Here’s Why
• Negative Sentiment: Coverage highlights ongoing pressure on management over capital allocation and the company’s multi-year underperformance, which could force unpalatable cost cuts or distract management. Teladoc faces pressure over capital allocation and stock underperformance (updated)
• Negative Sentiment: A shareholder class-action matter is active (investigations and motion to dismiss survived), adding legal risk and potential distraction for management. Grabar Law Office Investigates Claims on Behalf of Long-Term Investors of Teladoc Health, Inc. (TDOC) as Class Action Survives Motion to Dismiss

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.